and MAINZ, Germany, Jan. 27, 2025 (GLOBE NEWSWIRE ... the Company received formal notice from The Nasdaq Stock Market LLC (“Nasdaq”) confirming that it has regained compliance with the ...

Please visit Mainz Biomed’s official website for investors at mainzbiomed.com/investors/ for more information About Mainz Biomed NV Mainz Biomed develops market-ready molecular genetic diagnostic ...

BERKELEY, Calif. and MAINZ, Germany - Mainz Biomed NV (NASDAQ:MYNZ), a company focused on early cancer detection diagnostics, has announced its return to compliance with Nasdaq's stockholders' equity ...

Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing Requirements ...

and MAINZ, Germany, Jan. 27, 2025 (GLOBE NEWSWIRE ... the Company received formal notice from The Nasdaq Stock Market LLC (“Nasdaq”) confirming that it has regained compliance with the ...